Chi Sheng Chemical (4111) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Chi Sheng Chemical (4111) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$17.35 Million ≈ $546.49K USD) by net assets (NT$1.29 Billion ≈ $40.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Chi Sheng Chemical's balance sheet to measure how much of total assets are equity-financed.
Chi Sheng Chemical - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Chi Sheng Chemical's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 4111 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Chi Sheng Chemical Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Chi Sheng Chemical ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dr. Hönle AG
F:HNL
|
-0.001x |
|
DYPNF Co.Ltd
KQ:104460
|
0.048x |
|
UY Scuti Acquisition Corp.
NASDAQ:UYSC
|
N/A |
|
1895 of Wisconsin Inc Bancorp
NASDAQ:BCOW
|
0.003x |
|
Pasupati Acrylon Limited
NSE:PASUPTAC
|
0.013x |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
0.000x |
|
Wintao Communications Co. Ltd
SHE:301139
|
0.002x |
|
Dongsin Engineering & Construction
KQ:025950
|
-0.056x |
Annual Cash Flow Conversion Efficiency for Chi Sheng Chemical (2017–2024)
The table below shows the annual cash flow conversion efficiency of Chi Sheng Chemical from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see 4111 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.27 Billion ≈ $40.16 Million |
NT$213.20 Million ≈ $6.72 Million |
0.167x | +173.64% |
| 2023-12-31 | NT$1.22 Billion ≈ $38.41 Million |
NT$74.52 Million ≈ $2.35 Million |
0.061x | -65.23% |
| 2022-12-31 | NT$1.22 Billion ≈ $38.50 Million |
NT$214.86 Million ≈ $6.77 Million |
0.176x | +38.89% |
| 2021-12-31 | NT$1.10 Billion ≈ $34.68 Million |
NT$139.33 Million ≈ $4.39 Million |
0.127x | -5.13% |
| 2020-12-31 | NT$1.08 Billion ≈ $33.89 Million |
NT$143.53 Million ≈ $4.52 Million |
0.133x | -12.25% |
| 2019-12-31 | NT$1.07 Billion ≈ $33.77 Million |
NT$162.96 Million ≈ $5.13 Million |
0.152x | +39.15% |
| 2018-12-31 | NT$1.05 Billion ≈ $32.93 Million |
NT$114.19 Million ≈ $3.60 Million |
0.109x | -36.45% |
| 2017-12-31 | NT$1.05 Billion ≈ $33.19 Million |
NT$181.14 Million ≈ $5.71 Million |
0.172x | -- |
About Chi Sheng Chemical
Chi Sheng Pharma & Biotech Co., Ltd manufactures, processes, imports, exports, and sells western medicines, cosmetics, health food products, medical devices, and animal medicines in Taiwan and internationally. Its product portfolio includes antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic … Read more